Finally, the Government of India has agreed to ease sanctions on the supply of hydroxychloroquine to the United States.
However, the lift of ban on this anti-malaria drug will only be partial.
Indian PM Narendra Modi has reportedly taken this decision after US President Donald Trump urged him over a telephonic conversation on April 05, 2020.
And, Trump looks at this drug as a ‘gamechanger’ in controlling COVID-19.
“I would be surprised if that (not exporting the drug) were his (Prime Minister Modi’s) decision. He’d have to tell me that. I spoke to him Sunday morning, called him, and I said we’d appreciate your allowing our supply to come out. If he doesn’t allow it to come out, that would be okay, but of course there may be retaliation. Why wouldn’t there be?” Donald Trump said in a statement.
The Indian Government has eased sanctions on hydroxychloroquine and paracetamol on a case-by-case basis, and will license the drugs only in appropriate quantities to all the neighboring nations.
“It has been decided that India would license paracetamol and HCQ in appropriate quantities to all our neighboring countries who are dependent on our capabilities,” Indian Foreign Ministry Spokesman Anurag Srivatsava said in a statement.
The government had called for the ban of this drug last month after the Indian Council of Medical Research (ICMR) said the drug is for patients at high risk of contracting the virus.
More COVID19 Articles:
- COVID-19 India: Rise in Positive Cases Likely As Testing Expands
- COVID-19 India: Govt Gears Up for Post Lockdown Measures
- COVID-19 India: Rapid Tests/Day To Double For Every 3 Days
- COVID-19 India: Post Lockdown Plans Underway, Another Package Likely!
- COVID-19: DRDO Prepares ‘Bio-suits’ for Medical Staff Safety
- COVID-19 India: ‘Light Candles For 9 Mins on April 05,” PM Tells Public
- COVID-19 India: 65% of New Cases Linked To Tablighi Jamaat Meet